BioCentury
ARTICLE | Clinical News

Limtop imiquimod: Completed Phase II enrollment

September 10, 2012 7:00 AM UTC

Moberg completed enrollment of 97 patients in a double-blind, placebo-controlled, German Phase II trial evaluating topical Limtop given 1, 3 or 7 times weekly. ...